Found: 57
Select item for more details and to access through your institution.
Genetic and molecular mechanisms in multiple myeloma: a route to better understand disease pathogenesis and heterogeneity.
- Published in:
- Application of Clinical Genetics, 2010, v. 3, p. 41
- By:
- Publication type:
- Article
Pembrolizumab-induced Remission After Failure of Axicabtagene Ciloleucel: Case Report and Literature Review.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Validation of the simplified International Prognostic Score3 in a Hellenic cohort of patients with advanced‐stage Hodgkin‐lymphoma.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 6, p. e335, doi. 10.1111/bjh.16903
- By:
- Publication type:
- Article
The oncogenic JUNB/ CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 4, p. 514, doi. 10.1111/bjh.13079
- By:
- Publication type:
- Article
mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated acute myeloid leukemia cells.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 292, doi. 10.1186/1476-4598-9-292
- By:
- Publication type:
- Article
Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. E299, doi. 10.1002/ajh.26600
- By:
- Publication type:
- Article
Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: association with BRAF/ERK activation and clinical outcome.
- Published in:
- Scientific Reports, 2016, p. 21252, doi. 10.1038/srep21252
- By:
- Publication type:
- Article
Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndrome.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4480, doi. 10.3390/cancers13174480
- By:
- Publication type:
- Article
The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 5, p. 2056, doi. 10.1002/cam4.2090
- By:
- Publication type:
- Article
CD138 expression helps distinguishing Waldenström's macroglobulinemia (WM) from splenic marginal zone lymphoma (SMZL)
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Novel M-component based biomarkers in Waldenström's macroglobulinemia.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Novel M-Component Based Biomarkers in Waldenström's Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 164, doi. 10.3816/CLML.2011.n.039
- By:
- Publication type:
- Article
CD138 Expression Helps Distinguishing Waldenström's Macroglobulinemia (WM) From Splenic Marginal Zone Lymphoma (SMZL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 99, doi. 10.3816/CLML.2011.n.019
- By:
- Publication type:
- Article
Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia.
- Published in:
- Advances in Hematology, 2013, p. 1, doi. 10.1155/2013/359071
- By:
- Publication type:
- Article
Study of bone metabolism and angiogenesis in patients undergoing high‐dose chemotherapy/autologous hematopoietic stem cell transplantation.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 2, p. 131, doi. 10.1111/ejh.12990
- By:
- Publication type:
- Article
Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab.
- Published in:
- European Journal of Haematology, 2006, v. 77, n. 4, p. 300, doi. 10.1111/j.1600-0609.2006.00720.x
- By:
- Publication type:
- Article
Lymphoma: Methods and Protocols.
- Published in:
- 2006
- By:
- Publication type:
- Book Review
Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time‐limited venetoclax/obinutuzumab treatment.
- Published in:
- Clinical Case Reports, 2021, v. 9, n. 7, p. 1, doi. 10.1002/ccr3.4514
- By:
- Publication type:
- Article
Richter's transformation as leptomeningeal infiltration in a chronic lymphocytic leukemia patient receiving venetoclax. Could blood‐brain barrier be a disease "sanctuary" during venetoclax treatment?
- Published in:
- Clinical Case Reports, 2021, v. 9, n. 4, p. 2249, doi. 10.1002/ccr3.4002
- By:
- Publication type:
- Article
P-085: Updated outcomes on Lenalidomide (Len) refractory MM patients'.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S85, doi. 10.1016/S2152-2650(21)02219-9
- By:
- Publication type:
- Article
Lenalidomide (Len) Refractory MM Patients' Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e160, doi. 10.1016/j.clml.2019.09.268
- By:
- Publication type:
- Article
Prognostic value and clinical correlations of serum cereblon (CRBN) levels in multiple myeloma patients treated with Lenalidomide/Dexamethasone (RD).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e117, doi. 10.1016/j.clml.2019.09.194
- By:
- Publication type:
- Article
Validation of Frailty Assessment in Multiple Myeloma (MM) Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e137, doi. 10.1016/j.clml.2017.03.247
- By:
- Publication type:
- Article
Bone metabolism markers and angiogenic cytokines as regulators of human hematopoietic stem cell mobilization.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00668-8
- By:
- Publication type:
- Article
Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 10, p. 1, doi. 10.1038/s41408-021-00555-8
- By:
- Publication type:
- Article
Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher‐risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 4, p. 541, doi. 10.1002/hon.2756
- By:
- Publication type:
- Article
The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Re-evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents.
- Published in:
- Hematological Oncology, 2013, v. 31, n. 2, p. 356, doi. 10.1002/hon.2026
- By:
- Publication type:
- Article
The prognostic value of monosomal karyotype (MK) in higher‐risk patients with myelodysplastic syndromes treated with 5‐Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. 895, doi. 10.1002/ajh.25111
- By:
- Publication type:
- Article
A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 9, p. 900, doi. 10.1002/ajh.24430
- By:
- Publication type:
- Article
Activity and tolerability of nilotinib: a retrospective multicenter analysis of chronic myeloid leukemia patients who are imatinib resistant or intolerant.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Activity and Tolerability of Nilotinib.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 19, p. 4564, doi. 10.1002/cncr.25351
- By:
- Publication type:
- Article
Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
- Published in:
- British Journal of Haematology, 2007, v. 137, n. 3, p. 240, doi. 10.1111/j.1365-2141.2007.06561.x
- By:
- Publication type:
- Article
Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up or acute myeloid leukaemia transformation: incidence and their prognostic significance.
- Published in:
- British Journal of Haematology, 2006, v. 134, n. 3, p. 302, doi. 10.1111/j.1365-2141.2006.06171.x
- By:
- Publication type:
- Article
Early-Stage Gastric MALT Lymphoma: Is It a Truly Localized Disease?
- Published in:
- Oncologist, 2009, v. 14, n. 2, p. 148, doi. 10.1634/theoncologist.2008-0178
- By:
- Publication type:
- Article
The Role of Methylation in Chronic Lymphocytic Leukemia and Its Prognostic and Therapeutic Impacts in the Disease: A Systematic Review.
- Published in:
- Advances in Hematology, 2024, v. 2024, p. 1, doi. 10.1155/2024/1370364
- By:
- Publication type:
- Article
Influenza Virus Vaccine in B-Cell Chronic Lymphocytic Leukaemia Patients.
- Published in:
- Acta Haematologica, 1994, v. 91, n. 3, p. 115, doi. 10.1159/000204315
- By:
- Publication type:
- Article
Serum Procalcitonin Levels in Newly Diagnosed Hodgkin Lymphoma: Correlation with Other Inflammatory Biomarkers.
- Published in:
- Medicina (1010660X), 2022, v. 58, n. 10, p. 1331, doi. 10.3390/medicina58101331
- By:
- Publication type:
- Article
TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in Greece.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 8, p. 1, doi. 10.3390/medicina57080827
- By:
- Publication type:
- Article
Incorporating Monoclonal Antibodies into the First-Line Treatment of Classical Hodgkin Lymphoma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 17, p. 13187, doi. 10.3390/ijms241713187
- By:
- Publication type:
- Article
Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry-based cohort study.
- Published in:
- EJHaem, 2020, v. 1, n. 1, p. 1, doi. 10.1002/jha2.30
- By:
- Publication type:
- Article
New Insights into Malignant B-Cell Disorders.
- Published in:
- BioMed Research International, 2015, v. 2015, p. 1, doi. 10.1155/2015/128084
- By:
- Publication type:
- Article
Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Clonotypic Analysis of Immunoglobulin Heavy Chain Sequences in Patients with Waldenström's Macroglobulinemia: Correlation with MYD88 L265P Somatic Mutation Status, Clinical Features, and Outcome.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/809103
- By:
- Publication type:
- Article
New Insights into Monoclonal B-Cell Lymphocytosis.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/258917
- By:
- Publication type:
- Article
Immunohistochemical Analysis of IL-6, IL-8/CXCR2 Axis, <sup>Tyr</sup>p-STAT-3, and SOCS-3 in Lymph Nodes from Patients with Chronic Lymphocytic Leukemia: Correlation between Microvascular Characteristics and Prognostic Significance.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/251479
- By:
- Publication type:
- Article